| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1098-3597(03)90044-5 |
| P698 | PubMed publication ID | 15035556 |
| P50 | author | Michael McClung | Q35705017 |
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. | Q31921266 | ||
| Randomised factorial trial of falls prevention among older people living in their own homes | Q33892436 | ||
| Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial | Q34180229 | ||
| Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group | Q34409983 | ||
| Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial | Q34485941 | ||
| Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women | Q36885057 | ||
| Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds | Q40660025 | ||
| World-wide projections for hip fracture | Q40909953 | ||
| Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators | Q43988923 | ||
| Prevention of hip fracture in elderly people with use of a hip protector | Q44992439 | ||
| How Hip and Whole-Body Bone Mineral Density Predict Hip Fracture in Elderly Women: The EPIDOS Prospective Study | Q60611644 | ||
| Fall-related factors and risk of hip fracture: the EPIDOS prospective study | Q60611647 | ||
| Epidemiology of osteoporosis | Q73092921 | ||
| A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group | Q74341821 | ||
| P921 | main subject | osteoporosis | Q165328 |
| P304 | page(s) | S22-9 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Clinical cornerstone | Q27714621 |
| P1476 | title | Pathogenesis of osteoporotic hip fractures | |
| P478 | volume | Suppl 2 |
| Q40313121 | Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study |
| Q39733558 | Bone health in urban midlife Malaysian women: risk factors and prevention |
| Q50111825 | Mortality after hip fracture in Austria 2008-2011. |
| Q39109115 | Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey. |
| Q26776103 | Silicon as Versatile Player in Plant and Human Biology: Overlooked and Poorly Understood |
Search more.